Replies to post #4686 on Halozyme Therapeutics Inc (HALO)

[maumar]

What's also confusing is that Perjeta Sc is in the presentation slides but not in the pipeline on Halo's website. And does Roche also have their own formulation of Perjeta SC? Are they testing two formulations?

"Experimental: Cohort 8: SC Perjeta 1200 mg (Without rHuPH20) + SC Herceptin
Cohort 8 will include healthy male volunteers from Part 1. A single, mixed SC injection containing 1200 mg Perjeta (formulated without recombinant human hyaluronidase [rHuPH20] as an excipient) and 600 mg Herceptin will be administered."

https://clinicaltrials.gov/ct2/show/NCT02738970